Seroprevalence and risk factors for hepatitis A, B, and C in a reference unit for special infectious and parasitic diseases, in Belém, Pará State, Brazil/Soroprevalência e fatores de risco das hepatites A, B e C em uma unidade de referência de doenças infecciosas e parasitárias especiais, em Belém, estado do Pará, Brasil

Alves, Natália Guedes; Abraão, Luciano Sami de Oliveira; Miranda, Esther Castello Branco Mello; Araujo Junior, José Raul Rocha de; Malheiros, Andreza Pinheiro; Nunes, Heloisa Marceliano.
Rev. Pan-Amaz. Saude ; 13(e202200942)2022.
Artigo em Português | Instituto Evandro Chagas (SOPHIA) | ID: iec-20892

Documentos relacionados

  1. Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study.
  2. Seroprevalence of HBV and HCV in female sex workers from four cities in the state of Pará, northern Brazil.
  3. Seroprevalence of Hepatitis B and C Virus Infections among Healthcare Seekers at a Tertiary Health Facility in North-Central Nigeria: A Retrospective Study.
  4. Seroprevalence of hepatitis B, C, and D and associated factors in the semi-isolated Yanomami Amazonian indigenous community.
  5. Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.
  6. VirA+EmiC project: Evaluating real-world effectiveness and sustainability of integrated routine opportunistic hepatitis B and C testing in a large urban emergency department.
  7. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study.
  8. Seroprevalence of HBV and HCV Among Diabetes Mellitus Patients Attending University of Gondar Hospital, Northwest Ethiopia.
  9. Analytical performance of newly developed rapid point-of-care test for the simultaneous detection of hepatitis A, B, and C viruses in serum samples.
  10. High-speed centrifugation rather than Lipoclear reagent can be used for removing the interference of lipemia on serological tests of infectious diseases: AIDS, hepatitis B, hepatitis C, and syphilis by chemiluminescent microparticle immunoassay.